Related Experiment Video
Updated: Mar 14, 2026
10:09
Leprdb Mouse Model of Type 2 Diabetes: Pancreatic Islet Isolation and Live-cell 2-Photon Imaging Of Intact Islets
Published on: May 11, 2015
10.1K
Identification and Characterization of microRNAs Associated With Human β-Cell Loss in a Mouse Model.
R Roat1, M M Hossain1, J Christopherson1
1The Sanford Project, Sanford Research, Sioux Falls, SD.
Summary
Researchers developed a mouse model to study early beta-cell loss after human islet transplantation (HIT). They identified circulating microRNAs, miR-4454 and miR-199a-5p, as potential biomarkers for detecting graft rejection.
Area of Science:
- Immunology
- Endocrinology
- Molecular Biology
Background:
- Human islet transplantation (HIT) lacks effective methods to monitor early beta-cell loss during graft rejection.
- Studying human islet destruction in vivo is challenging due to ethical and technical limitations.
Purpose of the Study:
- To establish a humanized mouse model for inducing and studying early human beta-cell death.
- To identify circulating biomarkers indicative of early beta-cell loss in HIT.
Main Methods:
- Developed a humanized mouse model using adoptive lymphocyte transfer (ALT) to induce human beta-cell death.
- Validated the model using islet-specific miR-375 as a biomarker.
- Utilized NanoString expression assay and quantitative real-time PCR to profile and validate microRNAs in grafts and circulation.
Main Results:
- ALT-treated mice showed characteristic signs of graft rejection, including inflammation, reduced insulin-positive beta cells, and increased apoptosis.
- Circulating miR-375 levels decreased in grafts and increased in circulation preceding hyperglycemia.
- Identified decreased graft expression and increased circulating levels of miR-4454 and miR-199a-5p prior to hyperglycemia.
Conclusions:
- The established mouse model is effective for identifying circulating biomarkers of early beta-cell loss in HIT.
- miR-4454 and miR-199a-5p show promise as novel biomarkers for early detection of beta-cell destruction following human islet transplantation.
